{"id":4682,"date":"2013-12-30T12:36:56","date_gmt":"2013-12-30T11:36:56","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=4682"},"modified":"2013-12-30T12:36:56","modified_gmt":"2013-12-30T11:36:56","slug":"avaluacio-economica-de-medicaments","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2013\/12\/30\/avaluacio-economica-de-medicaments\/","title":{"rendered":"Evaluaci\u00f3n econ\u00f3mica de medicamentos"},"content":{"rendered":"<p>En uno <strong>escenario actual de restricciones presupuestarias que afectan directamente al \u00e1mbito sanitario es primordial saber evaluar econ\u00f3micamente<\/strong>. La farmaeconom\u00eda relaciona los gastos y beneficios que se derivan de prever diferentes alternativas frente a un tratamiento. Facilita, por tanto, tomar decisiones acertadas en la elecci\u00f3n de estrategias terap\u00e9uticas, optimiza los recursos y aumenta la eficiencia. <strong>Estos aspectos son los que ha tenido en cuenta la conferencia &quot;Evaluaci\u00f3n econ\u00f3mica de medicamentos&quot;<\/strong>, organizada por el Colegio conjuntamente con la Sociedad Catalana de Farmacia Cl\u00ednica (SCFC) el 27 de noviembre.<\/p>\n<p style=\"text-align: justify;\">El acto, patrocinado por <span style=\"text-decoration: underline;\">UCB<\/span> y coordinado por Tom\u00e0s Casas\u00edn, vocal de Hospitales del COFB; Roser Vall\u00e8s, vocal de Atenci\u00f3n Primaria del COFB y Julio Mart\u00ednez, presidente de la Sociedad Catalana de Farmacia Cl\u00ednica (SCFC), tuvo tres objetivos:<\/p>\n<p style=\"text-align: justify;\">En primer lugar, presentar las herramientas b\u00e1sicas para realizar estudios de evaluaci\u00f3n econ\u00f3mica en el campo de la salud de una forma pr\u00e1ctica y participativa.<\/p>\n<p style=\"text-align: justify;\">En segundo lugar, saber c\u00f3mo y d\u00f3nde buscar los datos necesarios para emprender un estudio econ\u00f3mico con revisi\u00f3n de la literatura de este tipo, la calidad de vida asociada a la salud y los valores coste-efectividad por patolog\u00eda.<\/p>\n<p style=\"text-align: justify;\">Por \u00faltimo, definir las fuentes existentes para realizar la valoraci\u00f3n y dotar al alumno de la capacidad para llevar a cabo este trabajo necesario para la toma de decisiones en el \u00e1mbito sanitario.<\/p>\n<p style=\"text-align: justify;\">El encargado de impartir estos conocimientos fue \u00c1lvaro Hidalgo, director del <i>Seminario de Investigaci\u00f3n en Econom\u00eda y Salud<\/i> de la UCLM y presidente del <i>Instituto Max Weber<\/i>, y los principales p\u00fablicos a los que iba dirigido fueron farmac\u00e9uticos de hospitales y centros de atenci\u00f3n primaria.<\/p>\n<h6 style=\"text-align: right;\"><span style=\"color: #888888;\">Con el patrocinio de:\u00a0<\/span><\/h6>\n<p><img decoding=\"async\" class=\"alignright\" alt=\"\" src=\"http:\/\/www.cofb.net\/image\/image_gallery?img_id=1353&amp;large=1&amp;key=79797\" \/><\/p>","protected":false},"excerpt":{"rendered":"<p>En un escenario actual de restricciones presupuestarias que afectan directamente al \u00e1mbito sanitario es primordial saber evaluar econ\u00f3micamente. La farmaeconom\u00eda relaciona los gastos y beneficios que se derivan de prever diferentes alternativas frente a un tratamiento. Facilita, pues, tomar decisiones acertadas en la elecci\u00f3n de estrategias terap\u00e9uticas, optimiza los recursos y aumenta [\u2026]<\/p>","protected":false},"author":1,"featured_media":4692,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[70],"class_list":["post-4682","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-formacio"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Avaluaci\u00f3 econ\u00f2mica de medicaments - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Avaluaci\u00f3 econ\u00f2mica de medicaments - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"En un escenari actual de restriccions pressupost\u00e0ries que afecten directament a l\u2019\u00e0mbit sanitari \u00e9s cabdal saber avaluar econ\u00f2micament. La farmaeconomia relaciona les despeses i els beneficis que es deriven de preveure diferents alternatives davant d\u2019un tractament. Facilita, doncs, prendre decisions encertades en l\u2019elecci\u00f3 d\u2019estrat\u00e8gies terap\u00e8utiques, optimitza els recursos i augmenta [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-12-30T11:36:56+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Avaluaci\u00f3 econ\u00f2mica de medicaments\",\"datePublished\":\"2013-12-30T11:36:56+00:00\",\"dateModified\":\"2013-12-30T11:36:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/\"},\"wordCount\":310,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Formaci\u00f3\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/\",\"name\":\"Avaluaci\u00f3 econ\u00f2mica de medicaments - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2013-12-30T11:36:56+00:00\",\"dateModified\":\"2013-12-30T11:36:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Avaluaci\u00f3 econ\u00f2mica de medicaments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Avaluaci\u00f3 econ\u00f2mica de medicaments - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/","og_locale":"es_ES","og_type":"article","og_title":"Avaluaci\u00f3 econ\u00f2mica de medicaments - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"En un escenari actual de restriccions pressupost\u00e0ries que afecten directament a l\u2019\u00e0mbit sanitari \u00e9s cabdal saber avaluar econ\u00f2micament. La farmaeconomia relaciona les despeses i els beneficis que es deriven de preveure diferents alternatives davant d\u2019un tractament. Facilita, doncs, prendre decisions encertades en l\u2019elecci\u00f3 d\u2019estrat\u00e8gies terap\u00e8utiques, optimitza els recursos i augmenta [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2013-12-30T11:36:56+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Avaluaci\u00f3 econ\u00f2mica de medicaments","datePublished":"2013-12-30T11:36:56+00:00","dateModified":"2013-12-30T11:36:56+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/"},"wordCount":310,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/#primaryimage"},"thumbnailUrl":"","keywords":["Formaci\u00f3"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/","url":"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/","name":"Avaluaci\u00f3 econ\u00f2mica de medicaments - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/#primaryimage"},"thumbnailUrl":"","datePublished":"2013-12-30T11:36:56+00:00","dateModified":"2013-12-30T11:36:56+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2013\/12\/30\/avaluacio-economica-de-medicaments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Avaluaci\u00f3 econ\u00f2mica de medicaments"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"En un escenari actual de restriccions pressupost\u00e0ries que afecten directament a l\u2019\u00e0mbit sanitari \u00e9s cabdal saber avaluar econ\u00f2micament. La farmaeconomia relaciona les despeses i els beneficis que es deriven de preveure diferents alternatives davant d\u2019un tractament. Facilita, doncs, prendre decisions encertades en l\u2019elecci\u00f3 d\u2019estrat\u00e8gies terap\u00e8utiques, optimitza els recursos i augmenta [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/4682","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=4682"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/4682\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=4682"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=4682"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=4682"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}